Real-world treatment patterns and burden-of-disease of sub-optimally controlled hereditary angioedema
Suboptimal disease control in HAE was associated with the use of ODT only, as well as LTP mainly with AA/TA. It imposes a substantial burden on patients' HRQoL, more particularly, but not exclusively, for those with frequent attacks and for women. The results suggest a need for improved HAE management.ClinicalTrial.gov study identifier NCT04957641.
Authors
- Didier G. Ebo (ORCID: https://orcid.org/0000-0003-0672-7529)
- François Gavini
- Nawal Bent‐Ennakhil (ORCID: https://orcid.org/0000-0001-7552-2004)
- Irmgard Andresen
- Emel Aygören‐Pürsün
- Fotis Psarros
- N. Bara
- Laura Sayegh
Institutions
- Semmelweis University (HU)
- Goethe University Frankfurt (DE)
- Takeda (Switzerland) (CH)
- Thermo Fisher Scientific (Canada) (CA)
- Antwerp University Hospital (BE)
- University Hospital Frankfurt (DE)
- Spitalul Clinic Judetean Mures (RO)
- Athens Naval & Veterans Hospital (GR)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.waojou.2025.101100
- Citations
- 1
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 1.63